The Leading IR and Communications Practice in Life Sciences

For more than 20 years, Solebury Strategic Communications has helped life sciences companies–both public and private–raise capital and increase share value through access to leading global investors and management of complex communications challenges. With more than 70 dedicated professionals, Solebury Strategic Communications team members have expertise in investor relations, equity research, investment banking, corporate communications and media relations.

Solebury Strategic Communications is affiliated with leading equity capital markets advisory firm Solebury Capital, which has advised on 30 percent of the IPO proceeds in the United States since 2021.